Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bimal V Patel

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Menopause (New York, N.Y.)|October 26, 2018
Evolution of postmenopausal hormone therapy between 2002 and 2009Bruce Ettinger, Sharon M Wang, R Scott Leslie, et al.
Vascular Health and Risk Management|October 2, 2008
Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimenBimal V Patel, R Scott Leslie, Patrick Thiebaud, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2026
Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in SwedenJohan Jendle, Nuno Picado, Carolina Bulhosa, et al.
The American Journal of Managed Care|January 9, 2026
HEDIS glycemic goal achieved using control-IQ TechnologyBimal V Patel, Sharon M Wang, Laurel H Messer, et al.
Diabetes, Obesity & Metabolism|May 5, 2026
Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United StatesNeda Al Rawashdh, Bimal V Patel, Sharon M Wang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2025
Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021Janna Manjelievskaia, Viral N Shah, Anders L Carlson, et al.
Diabetes Technology & Therapeutics|December 30, 2025
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 DiabetesJolien De Meulemeester, Francesca Fiorentino, Nuno Picado, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Menopause (New York, N.Y.)|October 26, 2018
Evolution of postmenopausal hormone therapy between 2002 and 2009Bruce Ettinger, Sharon M Wang, R Scott Leslie, et al.
Vascular Health and Risk Management|October 2, 2008
Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimenBimal V Patel, R Scott Leslie, Patrick Thiebaud, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2026
Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in SwedenJohan Jendle, Nuno Picado, Carolina Bulhosa, et al.
The American Journal of Managed Care|January 9, 2026
HEDIS glycemic goal achieved using control-IQ TechnologyBimal V Patel, Sharon M Wang, Laurel H Messer, et al.
Diabetes, Obesity & Metabolism|May 5, 2026
Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United StatesNeda Al Rawashdh, Bimal V Patel, Sharon M Wang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2025
Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021Janna Manjelievskaia, Viral N Shah, Anders L Carlson, et al.
Diabetes Technology & Therapeutics|December 30, 2025
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 DiabetesJolien De Meulemeester, Francesca Fiorentino, Nuno Picado, et al.
Pageof 3